Joseph Buzogany, MD
Forensic Psychiatry · Indiana, PANPI 1386662609
Payments from drug & device makers
Across 375 payments — averaging $13.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- AbbVie$931
- Otsuka America Pharmaceutical, Inc.$313
- Neurocrine Biosciences, Inc.$306
- Sunovion Pharmaceuticals Inc.$289
- Novartis$289
- plus $2K from 31 others
What the payments were for
- Speaking & faculty fees$301%
- Food & beverage$5,20699%
- Gifts$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 108 | $1,115 |
| AbbVie(2 entities) | 75 | $931 |
| Otsuka America Pharmaceutical, Inc. | 17 | $313 |
| Neurocrine Biosciences, Inc. | 18 | $306 |
| Sunovion Pharmaceuticals Inc. | 19 | $289 |
| Novartis | 18 | $289 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $242 |
| Lundbeck LLC | 14 | $224 |
| Alkermes, Inc. | 10 | $190 |
| UCB, Inc. | 6 | $134 |
| Acadia Pharmaceuticals Inc | 8 | $128 |
| Vanda Pharmaceuticals Inc. | 6 | $120 |
| Indivior Inc. | 7 | $111 |
| Greenwich Biosciences, Inc. | 7 | $105 |
| Merck | 5 | $70 |
| Lilly USA, LLC | 4 | $60 |
| Upsher-smith Laboratories LLC | 3 | $55 |
| Corium, LLC | 4 | $53 |
| Amgen | 4 | $53 |
| Kyowa Kirin, Inc. | 3 | $50 |
| Johnson & Johnson | 3 | $50 |
| Harmony Biosciences LLC | 2 | $43 |
| Eisai Inc. | 2 | $38 |
| Abbott | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $34 |
| Acorda Therapeutics, Inc | 2 | $30 |
| Ironshore Pharmaceuticals Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Banner Life Sciences, LLC | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Bristol Myers Squibb | 1 | $14 |
| SK Life Science, Inc. | 1 | $14 |
| Validus Pharmaceuticals LLC | 2 | $3 |
How this compares
Too few forensic psychiatry providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 38 | $3,019 |
| Escitalopram Oxalate | 39 | $604 |
| Lamotrigine | 44 | $548 |
| Buspirone Hcl | 28 | $325 |
| Quetiapine Fumarate | 28 | $313 |
| Trazodone Hcl | 45 | $293 |
| Risperidone | 34 | $284 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 17 | $232 |
| Duloxetine Hcl | 12 | $206 |
| Sertraline Hcl | 21 | $127 |
| Clonazepam | 12 | $127 |
| Hydroxyzine Pamoate | 14 | $112 |
Paid to pharmacies, not to this prescriber.
Other forensic psychiatry in Indiana
- Robert DavisMechanicsburg$2K
- Lutfi YargicPittsburgh$400
- Evan FeibuschNewtown$333
- Babatunde AdetunjiPhiladelphia$139
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.